A detailed history of Stifel Financial Corp transactions in Quest Diagnostics Inc stock. As of the latest transaction made, Stifel Financial Corp holds 71,702 shares of DGX stock, worth $9.83 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
71,702
Previous 73,908 2.98%
Holding current value
$9.83 Million
Previous $10.1 Million 2.84%
% of portfolio
0.01%
Previous 0.01%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$137.09 - $137.09 $302,420 - $302,420
-2,206 Reduced 2.98%
71,702 $9.83 Million
Q2 2024

Aug 13, 2024

SELL
$125.91 - $144.34 $732,922 - $840,203
-5,821 Reduced 7.3%
73,908 $10.1 Million
Q1 2024

May 13, 2024

BUY
$123.78 - $142.11 $1.2 Million - $1.38 Million
9,680 Added 13.82%
79,729 $10.6 Million
Q4 2023

Feb 12, 2024

SELL
$120.62 - $141.12 $281,768 - $329,656
-2,336 Reduced 3.23%
70,049 $9.66 Million
Q3 2023

Nov 13, 2023

BUY
$121.86 - $144.92 $521,560 - $620,257
4,280 Added 6.28%
72,385 $8.82 Million
Q2 2023

Aug 14, 2023

SELL
$130.56 - $146.84 $443,904 - $499,256
-3,400 Reduced 4.75%
68,105 $9.57 Million
Q1 2023

May 12, 2023

SELL
$131.53 - $155.76 $6.81 Million - $8.07 Million
-51,799 Reduced 42.01%
71,505 $10.1 Million
Q4 2022

Feb 13, 2023

SELL
$123.31 - $157.26 $1.59 Million - $2.02 Million
-12,876 Reduced 9.46%
123,304 $19.3 Million
Q3 2022

Nov 14, 2022

SELL
$121.77 - $141.1 $21,918 - $25,398
-180 Reduced 0.13%
136,180 $16.7 Million
Q2 2022

Aug 15, 2022

SELL
$127.07 - $145.39 $207,251 - $237,131
-1,631 Reduced 1.18%
136,360 $18.1 Million
Q1 2022

May 13, 2022

SELL
$129.09 - $164.35 $141,353 - $179,963
-1,095 Reduced 0.79%
137,991 $18.9 Million
Q4 2021

Feb 14, 2022

SELL
$140.36 - $173.01 $349,075 - $430,275
-2,487 Reduced 1.76%
139,086 $24.1 Million
Q3 2021

Nov 15, 2021

BUY
$132.95 - $158.0 $476,093 - $565,798
3,581 Added 2.6%
141,573 $20.6 Million
Q2 2021

Aug 13, 2021

BUY
$126.66 - $141.48 $789,851 - $882,269
6,236 Added 4.73%
137,992 $18.2 Million
Q1 2021

May 14, 2021

SELL
$114.63 - $133.34 $232,011 - $269,880
-2,024 Reduced 1.51%
131,756 $16.9 Million
Q4 2020

Feb 12, 2021

SELL
$112.7 - $128.05 $2.18 Million - $2.47 Million
-19,319 Reduced 12.62%
133,780 $15.9 Million
Q3 2020

Nov 16, 2020

BUY
$107.05 - $130.01 $6.55 Million - $7.95 Million
61,173 Added 66.55%
153,099 $17.5 Million
Q2 2020

Aug 14, 2020

SELL
$73.34 - $122.61 $663,140 - $1.11 Million
-9,042 Reduced 8.96%
91,926 $10.5 Million
Q1 2020

May 14, 2020

SELL
$75.14 - $115.68 $817,297 - $1.26 Million
-10,877 Reduced 9.73%
100,968 $8.1 Million
Q4 2019

Feb 13, 2020

BUY
$100.29 - $107.99 $4.31 Million - $4.64 Million
42,969 Added 62.39%
111,845 $12 Million
Q3 2019

Nov 19, 2019

BUY
$97.85 - $107.42 $6,458 - $7,089
66 Added 0.1%
68,876 $7.37 Million
Q3 2019

Nov 13, 2019

BUY
$97.85 - $107.42 $160,082 - $175,739
1,636 Added 2.44%
68,810 $7.36 Million
Q2 2019

Aug 14, 2019

SELL
$85.18 - $101.94 $11.2 Million - $13.4 Million
-130,976 Reduced 66.1%
67,174 $6.84 Million
Q1 2019

May 14, 2019

BUY
$80.68 - $89.92 $1.3 Million - $1.45 Million
16,105 Added 8.85%
198,150 $17.8 Million
Q4 2018

Feb 13, 2019

BUY
$79.75 - $108.38 $12 Million - $16.3 Million
149,977 Added 467.68%
182,045 $15 Million
Q3 2018

Nov 13, 2018

BUY
$105.42 - $114.99 $428,743 - $467,664
4,067 Added 14.52%
32,068 $3.45 Million
Q2 2018

Aug 14, 2018

SELL
$97.35 - $113.14 $9.47 Million - $11 Million
-97,277 Reduced 77.65%
28,001 $3.07 Million
Q1 2018

May 11, 2018

BUY
$96.42 - $107.88 $451,438 - $505,094
4,682 Added 3.88%
125,278 $12.6 Million
Q4 2017

Feb 14, 2018

BUY
$90.86 - $100.24 $6.12 Million - $6.75 Million
67,367 Added 126.56%
120,596 $11.9 Million
Q3 2017

Nov 13, 2017

BUY
$91.96 - $108.35 $4.89 Million - $5.77 Million
53,229
53,229 $0

Others Institutions Holding DGX

About QUEST DIAGNOSTICS INC


  • Ticker DGX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 113,887,000
  • Market Cap $15.6B
  • Description
  • Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers dia...
More about DGX
Track This Portfolio

Track Stifel Financial Corp Portfolio

Follow Stifel Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stifel Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Stifel Financial Corp with notifications on news.